FOLH1 and metastatic malignant neoplasm in the lymph nodes: With [18F]F-PSMA-1007, 19 (38%) patients had PSMA-positive primary / local recurrence, 29 (58%) had PSMA-positive lymph node metastases and 19 (38%) had PSMA-positive bone metastases.